Discover why prominent investor Mukul Agrawal is betting big on a small-cap pharma company with massive growth potential. Get exclusive insights into his latest portfolio move and what it means for retail investors.
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Shocking data reveals 10.4 lakh vacant positions across central government departments, raising serious concerns about governance and service delivery in India.
St. Stephen's School, Sector 45, Chandigarh, successfully hosted an exhilarating inter-school cricket tournament, fostering sportsmanship and talent among young cricketers from across the city.
Khalra Mission Organisation condemns central government's alleged plans to privatize Punjab's power sector, warning of catastrophic consequences for farmers and domestic consumers in Amritsar and beyond.
Andhra Pradesh Chief Minister N. Chandrababu Naidu invites UAE business leaders to invest in state's thriving oil and gas industry, highlighting lucrative opportunities and investor-friendly policies.
CRISIL report reveals India's corporate sector shows 6% revenue growth in Q2 FY24, but IT services and steel sectors face significant slowdown. Discover which industries are driving growth.
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Vardhman Textiles reports 14% decline in Q2 profit to ₹189 crore with revenue down 2% as textile giant navigates market headwinds and demand pressures.
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
Prestige Group partners with Hilton to launch a premium mixed-use development in Bangalore's tech corridor, featuring luxury residences, upscale hotels, and premium retail spaces.
Hindustan Unilever reports strong Q2 performance with 3.6% revenue growth despite GST challenges. Rural markets show promising recovery signs while urban demand remains steady.
Tata Motors announces major corporate restructuring with commercial vehicles business demerger. Expert analysis reveals whether this strategic move makes the stock a buy.
Dalmia Bharat announces massive capacity expansion to 75 MTPA by 2027, investing ₹9,000 crore to capitalize on India's growing infrastructure demand and government spending initiatives.
Polycab India delivers impressive Q2 FY2024 results with 31% profit surge and 17% revenue growth. Discover how the wires and cables leader outperformed market expectations.
Adani Power Limited sets November 6, 2024, for its Q2 FY2025 results declaration. Discover what investors should watch for in this crucial earnings report from India's power sector giant.
Major Indian textile manufacturers witnessed massive stock surges as optimism grows around potential India-US trade agreement. Kitex Garments, Vardhman Textiles, and KPR Mill lead the rally with gains up to 17%.
India's IT sector faces turbulent times as major firms implement widespread layoffs while framing them as organizational restructuring. Discover the real impact on employees and the industry's shifting dynamics.
India's manufacturing sector shows remarkable growth with employment surging to 4.26 lakh across 14 key industries. Discover how sectors like automobiles, pharmaceuticals, and electronics are driving this employment boom.
Indian government accelerates disinvestment with strategic stake sales in IDBI Bank, OFS offerings, and IPO pipeline to boost capital receipts and meet asset monetisation targets in FY25.
AAP leader Kanwar Pal Singh Babla addresses critical civic issues in Chandigarh's Sector 35 - from water shortages to parking chaos and infrastructure gaps. Read how residents' concerns are being tackled.
British Prime Minister Rishi Sunak welcomes decisive US sanctions targeting two major Russian oil corporations, declaring Vladimir Putin must face consequences for his unprovoked war in Ukraine.
GE Vernova shares face significant pressure as investors worry about cooling electricity demand and slowing orders in key markets. Discover what's behind the sudden market shift.
In a shocking discovery, the body of a 25-year-old man was recovered from a drain in Chandigarh's Sector 32. Police have registered an FIR as investigations continue into the mysterious circumstances surrounding his death.
India accelerates toward 300GW renewable energy milestone with 40GW projects in advanced stages. Solar and wind lead the charge as nation transforms its power landscape.
In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.